There was a trend toward association between baseline beta‐blocker use and decreased incident HF in SSc; however, it did not reach statistical significance (aHR, 0.7 [95% CI, 0.5–1.0]; P =0.063).
← all excerpts
Heart Failure Risk in Patients With Systemic Autoimmune Inflammatory Diseases.
1
0.0630
0.0630